Bayer AG logo

BAYN - Bayer AG Share Price

€52.8 -0.1  -0.3%

Last Trade - 1:06pm

Large Cap
Market Cap £45.08bn
Enterprise Value £70.73bn
Revenue £35.88bn
Position in Universe 29th / 1046
Unlock BAYN Revenue
Relative Strength (%)
1m -3.19%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -28.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
46,085 34,943 35,015 36,742 43,545 41,400 41,059 42,426 -2.1%
+20.1 +5.3 -14.4 -25.5 +40.0 +11.1
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, Bayer AGrevenues decreased 5% to EUR41.4B. Net loss beforeextraordinary items totaled EUR15.57B vs. income ofEUR2.39B. Revenues reflect CropScience segment decrease of5% to EUR18.84B, Consumer Care segment decrease of 7% toEUR5.05B, Latin America segment decrease of 11% to EUR5.9B,North America segment decrease of 5% to EUR14.35B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BAYN
Graphical History


BAYN Revenue Unlock BAYN Revenue

Net Income

BAYN Net Income Unlock BAYN Revenue

Normalised EPS

BAYN Normalised EPS Unlock BAYN Revenue

PE Ratio Range

BAYN PE Ratio Range Unlock BAYN Revenue

Dividend Yield Range

BAYN Dividend Yield Range Unlock BAYN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BAYN EPS Forecasts Unlock BAYN Revenue
Profile Summary

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since November 28, 1997
No. of Shareholders: n/a
No. of Employees: 99,538
BAYN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BAYN
Upcoming Events for BAYN
Tuesday 27th April, 2021
Bayer AG Annual Shareholders Meeting
Wednesday 28th April, 2021
Dividend For BAYRY.PK - 0.5937 USD
Wednesday 28th April, 2021
Dividend For BAYGn.DE - 2.0000 EUR
Wednesday 12th May, 2021
Q1 2021 Bayer AG Earnings Release
Thursday 5th August, 2021
Q2 2021 Bayer AG Earnings Release
Frequently Asked Questions for Bayer AG
What is the Bayer AG share price?

As of 1:06pm, shares in Bayer AG are trading at €52.8, giving the company a market capitalisation of £45.08bn. This share price information is delayed by 15 minutes.

How has the Bayer AG share price performed this year?

Shares in Bayer AG are currently trading at €52.8 and the price has moved by -7.88% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bayer AG price has moved by -28.33% over the past year.

What are the analyst and broker recommendations for Bayer AG?

Of the analysts with advisory recommendations for Bayer AG, there are there are currently 7 "buy" , 11 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Bayer AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Bayer AG next release its financial results?

Bayer AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Bayer AG dividend yield?

The Bayer AG dividend yield is 3.78% based on the trailing twelve month period.

Does Bayer AG pay a dividend?

Last year, Bayer AG paid a total dividend of 2, and it currently has a trailing dividend yield of 3.78%. Looking ahead, shares in Bayer AG are due to go ex-dividend on 2021-04-28 and the next dividend pay date is 2021-04-30.

When does Bayer AG next pay dividends?

Bayer AG are due to go ex-dividend on 2021-04-28 and the next dividend pay date is 2021-04-30. The historic dividend yield on Bayer AG shares is currently 3.78%.

How do I buy Bayer AG shares?

To buy shares in Bayer AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bayer AG?

Shares in Bayer AG are currently trading at €52.8, giving the company a market capitalisation of £45.08bn.

Where are Bayer AG shares listed? Where are Bayer AG shares listed?

Here are the trading details for Bayer AG:

Country of listing: Germany
Exchange: GER
Ticker Symbol: BAYN
What kind of share is Bayer AG?

Based on an overall assessment of its quality, value and momentum, Bayer AG is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bayer AG share price forecast 2021?

Shares in Bayer AG are currently priced at €52.8. At that level they are trading at 21.14% discount to the analyst consensus target price of 0.00.

Analysts covering Bayer AG currently have a consensus Earnings Per Share (EPS) forecast of 5.805 for the next financial year.

How can I tell whether the Bayer AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bayer AG. Over the past six months, the relative strength of its shares against the market has been -0.38%. At the current price of €52.8, shares in Bayer AG are trading at 0.59% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bayer AG PE Ratio?

We were not able to find PE ratio data for Bayer AG.

Who are the key directors of Bayer AG?

Bayer AG's management team is headed by:

Paul Achleitner - IND
Oliver Zuehlke - VSU
Werner Baumann - CMG
Liam Condon - MGB
Simone Bagel-Trah - IND
Heiko Schipper - MGB
Norbert Bischofberger - IND
Thomas Elsner - IND
Stefan Oelrich - MGB
Wolfgang Nickl - CFO
Norbert Winkeljohann - CSU
Ertharin Cousin - IND
Sarena Lin - MGB
Who are the major shareholders of Bayer AG?

Here are the top five shareholders of Bayer AG based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 6.15% (60.4m shares)
Harris Associates L.P. Investment Advisor/Hedge Fund
Percentage owned: 3.02% (29.6m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 2.98% (29.3m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.6% (25.6m shares)
Amundi Asset Management Investment Advisor/Hedge Fund
Percentage owned: 2.44% (24.0m shares)
Similar to BAYN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.